Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MISSION: Somatrogon Weekly vs Daily Growth Hormone in Paediatric SGA or ISS
jRCT2051250256Recruiting
- Sponsor
- Schneider Children's Medical Center of Israel
- Start
- Mar 2026
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
01
Overview
Trial of somatrogon in Small for gestational age (SGA) and Idiopathic Short Stature (ISS) (2 arms), sponsored by Schneider Children's Medical Center of Israel. Primary endpoint: annualized height velocity at 12 months. Started Mar 2026; status: recruiting.
02
Drugs
somatrogon
03
Conditions
Small for gestational age (SGA)Idiopathic Short Stature (ISS)
Beyond the preview
Go deeper on jRCT2051250256.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2051250256.